Difference between revisions of "Fibrinogen alpha chain (TG2)"
m |
|||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Fibrinogen alpha chain |
|- | |- | ||
| Synonyms | | Synonyms | ||
| Line 12: | Line 9: | ||
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 15: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Extracellular; plasma |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P02671 P02671 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | Q328, Q366 |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | | + | | K148, K230, K303, K413 |
| + | |||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | GSTGN''Q''NPGSP |
| + | |||
| + | SGSTG''Q''WHSES | ||
| + | |||
| + | QLVDM''K''RELVD | ||
| + | |||
| + | VPPEW''K''ALTDM | ||
| + | |||
| + | GTATW''K''PGSSG | ||
| + | |||
| + | EYHTE''K''LVTSK | ||
| + | |||
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=1LT9 1LT9] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 42: | Line 51: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=10816585&dopt=Abstract PMID:10816585] |
|- | |- | ||
| Notes | | Notes | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:37, 10 March 2015
| Fibrinogen alpha chain (TG2) | |
|---|---|
| Substrate peptide name | Fibrinogen alpha chain |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02671 |
| Reactive glutamines | Q328, Q366 |
| Reactive lysines | K148, K230, K303, K413 |
| Substrate sequence | GSTGNQNPGSP
SGSTGQWHSES QLVDMKRELVD VPPEWKALTDM GTATWKPGSSG EYHTEKLVTSK |
| Structure | 1LT9 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10816585 |
| Notes | |
